Katie Dahlstrom
Chief Tech/Sci/R&D Officer at THESEUS PHARMACEUTICALS, INC.
Profile
Katie Dahlstrom is currently the Vice President-Clinical Development Operations at Theseus Pharmaceuticals, Inc. Previously, she worked as the Senior Director-Clinical Operations at Agios Pharmaceuticals, Inc. She completed her undergraduate degree at Stonehill College, Inc. and her graduate degree at Boston University School of Medicine.
Katie Dahlstrom active positions
| Companies | Position | Start |
|---|---|---|
| THESEUS PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | - |
Former positions of Katie Dahlstrom
| Companies | Position | End |
|---|---|---|
| AGIOS PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | - |
Training of Katie Dahlstrom
| Stonehill College, Inc. | Undergraduate Degree |
| Boston University School of Medicine | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| AGIOS PHARMACEUTICALS, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Theseus Pharmaceuticals, Inc.
 Theseus Pharmaceuticals, Inc. BiotechnologyHealth Technology Theseus Pharmaceuticals, Inc. engages in the development of pan-variant kinase inhibitors. It focuses on the discovery, development and commercialization of transformative targeted therapies. The company was founded by William C. Shakespeare, David C. Dalgarno, Iain D. Dukes, Wei Sheng Huang and Victor M. Rivera on December 29, 2017 and is headquartered in Cambridge, MA. | Health Technology |
- Stock Market
- Insiders
- Katie Dahlstrom
